The Lustgarten Foundation Innovation & Collaboration (I&C) Program supports high‑impact, collaborative pancreatic cancer research with clear potential to advance early detection, biology, and treatment. Projects are expected to be innovative, hypothesis‑driven, and team‑based, spanning basic, translational, and clinical domains. Multi‑PI and multi‑institutional projects are strongly encouraged.
Eligibility Criteria:
- Independent investigators at non‑profit academic, medical, or research institutions.
- Project must focus primarily on pancreatic cancer (biology, prevention, early detection, or therapy).
- Multidisciplinary, multi‑PI, or multi‑institutional collaborations are strongly encouraged.
- Open internationally, subject to institutional and funder compliance requirements.
Funding Details:
- Multi‑year research grants, typically 2–3 years in duration.
- Total budget generally in the low six‑figure range per year (exact cap and allowed costs per current RFA).
- Funds may support personnel, supplies, research‑related services, and limited equipment as defined in the guidelines.
Deadline:
- Current cycle full proposal deadline: January 5, 2026 (time zone per RFA).
- Award start: Mid‑2026 (exact date specified in award notice).
Where to go for further information: